monolay
cultur
human
embryo
lung
fibroblast
american
type
cultur
collect
atcc
grown
earl
modifi
minimum
essenti
medium
supplement
mm
aminoacid
mm
sodium
pyruv
fetal
bovin
serum
fb
antibiot
uml
penicillin
streptomycin
cell
cultur
medium
supplement
invitrogen
refer
strain
atcc
hcmv
use
vitro
infect
human
embryo
fibroblast
viral
infecti
titer
determin
plaqu
assay
alreadi
describ
arcangeletti
et
al
strain
use
multipl
infect
moi
unit
pfu
cell
stock
solut
mgml
actinomycin
prepar
dimethylsulfoxid
dmso
store
ad
cell
h
min
infect
final
concentr
monolay
infect
strain
moi
pfucel
incub
plan
time
presenc
cisplatin
ad
uninfect
fibroblast
h
final
concentr
stock
solut
mgml
dmso
store
withdrawn
infect
control
cell
similarli
incub
dilut
dmso
use
drug
dmso
purchas
fibroblast
plate
mm
round
glass
low
densiti
h
treat
drug
untreat
infect
strain
indic
time
situ
nuclear
matric
obtain
accord
arcangeletti
et
al
briefli
cell
monolay
rins
twice
tm
buffer
mm
ph
mm
incub
min
ice
tm
buffer
contain
mm
phenylmethylsulphonyl
fluorid
pmsf
triton
mm
wash
tm
buffer
supplement
mm
pmsf
cell
incub
min
tm
buffer
contain
unitsml
dnase
roch
diagnost
buffer
replac
tm
buffer
supplement
nacl
mm
pmsf
incub
min
ice
situ
nuclear
matric
wash
twice
tm
buffer
immedi
stain
detect
viral
antigen
indirect
immunofluoresc
chemic
follow
primari
antibodi
use
purifi
monoclon
blend
clone
react
kda
lower
matrix
structur
phosphoprotein
hcmv
argen
monoclon
antibodi
mab
clone
argen
specif
common
epitop
encod
exon
major
ie
viral
gene
product
serum
human
antiserum
nucleolar
antigen
bind
site
mab
dilut
bovin
serum
albumin
bsa
phosphat
buffer
salin
pb
mm
mm
ph
mm
nacl
mm
kcl
serum
use
undilut
tritc
goat
igg
fluorescein
isothiocyan
fitc
goat
igg
h
l
molecular
probe
use
detect
viral
antigen
nucleolar
protein
respect
immunofluoresc
indic
time
point
infect
cell
andor
situ
nuclear
matric
gentli
rins
cytoskeleton
csk
buffer
mm
pipe
acid
ph
mm
nacl
mm
mm
sucros
simultan
fix
permeabil
triton
formaldehyd
csk
buffer
room
temperatur
min
arcangeletti
et
al
fix
fibroblast
wash
three
time
minwash
pb
unspecif
immunoreact
site
satur
bsa
ph
pb
min
cell
incub
primari
antibodi
h
humid
chamber
three
wash
pb
secondari
antibodi
appli
alon
togeth
antibodi
case
immunofluoresc
min
humid
chamber
cell
nuclei
counterstain
dapi
neg
control
carri
ident
procedur
except
first
primari
antibodi
replac
bsa
pb
final
cell
mount
prolong
gold
anti
fade
reagent
molecular
probe
analyz
fluoresc
microscop
leica
dmlb
confoc
microscop
zeiss
lsm
meta
pattern
hcmv
nucleolar
protein
human
embryo
fibroblast
evalu
zeiss
lsm
meta
confoc
microscop
na
plan
apo
object
fitc
green
tritc
red
fluorochrom
excit
nm
argon
nm
laser
line
respect
acquisit
carri
multitrack
mode
relev
beamsplitt
barrier
filter
nm
band
pass
nm
long
pass
signal
respect
imag
result
averag
four
line
scan
order
reduc
nois
neg
control
examin
parallel
assess
specif
fitc
tritc
signal
absenc
background
mutual
green
red
signal
detect
seri
section
acquir
apex
base
cover
whole
height
sampl
primari
rrna
transcript
examin
revers
pcr
use
primer
specif
rrna
intern
transcrib
spacer
gene
product
length
bp
transcript
examin
primer
specif
third
intron
gene
product
length
bp
total
rna
extract
accord
manufactur
instruct
rnaii
integr
rna
examin
denatur
agaros
gel
electrophoresi
sampl
qualityquant
estim
measur
adsorb
nm
eppendorf
biophotomet
templat
rna
revers
transcrib
subject
pcr
amplif
use
forward
revers
primer
describ
accord
superscript
iii
one
step
platinum
taq
invitrogen
thermal
cycler
program
cdna
synthesi
follow
immedi
pcr
amplif
hereaft
detail
one
cycl
min
cdna
synthesi
cycl
cycl
intron
denatur
anneal
extens
min
amplif
product
run
agaros
gel
ethidium
bromid
stain
molecular
weight
marker
kb
plu
dna
ladder
bp
kb
invitrogen
previous
demonstr
jordan
et
al
jordan
verdun
low
concentr
abl
inhibit
rna
polymeras
transcript
leav
rna
polymeras
ii
also
necessari
viru
gene
transcript
rna
polymeras
iii
function
unaffect
order
verifi
inhibitor
exhibit
similar
effect
hcmv
human
embryo
fibroblast
preliminari
experi
perform
fig
total
rna
extract
uninfect
infect
cell
h
min
h
min
time
point
pi
follow
incub
presenc
absenc
two
inhibitor
extract
rna
revers
transcrib
subject
pcr
amplif
order
reveal
bp
rrna
fragment
correspond
intern
transcrib
spacer
fig
bp
sequenc
third
intron
fig
result
demonstr
significantli
inhibit
rrna
transcript
use
concentr
transcript
mrna
remain
unaffect
next
untreat
fibroblast
infect
hcmv
h
min
h
min
stain
antibodi
viral
protein
fig
nuclei
counterstain
dapi
alreadi
h
min
pi
accumul
ie
protein
within
nuclei
untreat
cell
clearli
visibl
nucleoplasm
treat
cell
discret
bright
spot
detect
fig
panel
c
e
similar
pattern
observ
h
min
pi
fig
panel
b
f
although
case
fluoresc
signal
slightli
increas
cell
arrow
panel
result
suggest
suppress
nucleolar
gene
transcript
somehow
block
develop
hcmv
infect
importantli
inhibit
rrna
transcript
result
deplet
ribosom
within
cytoplasm
demonstr
comparison
quantiti
rrna
present
equival
aliquot
see
gapdh
signal
rna
extract
uninfect
control
cell
versu
cell
treat
rrna
transcript
inhibitor
fig
rna
sampl
analyz
electrophoresi
intens
band
quantifi
densitometr
analysi
data
obtain
four
independ
experi
submit
statist
analysi
anova
shown
demonstr
signific
differ
amount
rrna
experiment
condit
use
suppress
rrna
transcript
previous
publish
arcangeletti
et
al
tegument
protein
incom
hcmv
preferenti
target
nucleoli
infect
cell
soon
infect
figur
show
confoc
microscopi
imag
nucleolar
protein
green
red
fibroblast
min
h
min
h
min
pi
absenc
rrna
transcript
inhibitor
fig
panel
follow
treatment
either
fig
panel
fig
panel
redistribut
nucleolar
protein
observ
fig
panel
gradual
process
consequ
cell
treatment
either
exactli
cell
treat
although
signific
level
nucleoplasm
redistribut
nucleolar
protein
observ
nucleoli
still
detect
even
h
min
pi
ie
h
treatment
sinc
cell
drug
h
min
infect
see
materi
method
section
detail
fig
panel
f
differ
kinet
observ
viral
cell
treat
viral
protein
alreadi
fulli
displac
nucleolar
compart
min
pi
ie
h
min
start
treatment
cell
h
nucleolar
protein
alreadi
distribut
throughout
entir
nuclear
space
otherwis
displac
perinucleolar
compart
min
pi
fig
panel
g
viral
similarli
distribut
min
pi
fig
panel
connect
result
outlin
nucleoli
visual
use
polyclon
serum
rais
mixtur
nucleolar
antigen
differ
nucleolar
protein
like
show
differ
affin
nucleolu
particular
relat
rrna
synthesi
moreov
presenc
within
compart
may
differenti
affect
inhibit
rrna
transcript
thu
possibl
specif
nucleolar
protein
displac
kinet
follow
treatment
next
set
experi
cell
extract
order
obtain
situ
nuclear
matric
residu
nucleoli
inspect
absenc
hcmv
well
differ
time
infect
control
cell
cell
treat
either
fig
case
time
cours
kinet
shorten
compar
unestract
nuclei
order
analyz
event
occur
initi
stage
hcmv
infect
nucleolar
matrix
still
detect
cell
begin
viru
infect
fig
panel
g
although
signific
redistribut
nucleolar
protein
nucleoplasm
quit
evid
compar
panel
g
fig
similar
pattern
nucleolar
protein
stain
observ
min
pi
fig
panel
e
h
time
point
coloc
remnant
nucleoli
infect
treat
cell
white
arrow
panel
e
h
min
pi
remnant
nucleoli
practic
absent
nuclear
matric
treat
cell
fig
panel
f
nevertheless
sever
case
perinucleolar
ring
still
detect
similar
pattern
observ
fig
panel
base
result
conclud
exist
nucleolar
matrix
drastic
depend
ongo
transcript
ribosom
gene
furthermor
result
show
initi
target
releas
nucleolar
matrix
complet
disassembl
import
nuclear
compartment
regul
gene
express
becom
increasingli
evid
pliss
et
al
gorski
et
al
malyavantham
et
al
mist
one
best
character
nuclear
compart
nucleolu
present
consid
ribosom
factori
also
multifunct
area
involv
sever
cellular
process
includ
mrna
matur
shuttl
cytoplasm
site
control
cell
cycl
cell
prolifer
apoptosi
pederson
verdun
also
worth
mention
import
nucleolar
protein
known
dna
andor
rna
bind
properti
regulatori
function
rrna
synthesi
cell
cycl
control
like
nucleophosmin
nucleolin
grinstein
et
al
ugrinova
et
al
also
found
associ
nuclear
matrix
thu
might
abl
affect
whole
system
nuclear
compartment
mittnacht
weinberg
dickinson
yun
et
al
nucleolu
frequent
target
differ
dna
rna
virus
lytic
infect
protein
often
accumul
nucleoli
form
complex
nucleolar
antigen
miyazaki
et
al
bess
matthew
pokrovskaja
et
al
chen
et
al
hiscox
boyn
whitehous
michienzi
et
al
shimakami
et
al
et
al
anoth
scenario
redistribut
nucleolar
protein
within
nucleoplasm
cytoplasm
caus
viral
infect
matthew
bevington
et
al
et
al
articl
show
earli
nucleolar
compartment
major
tegument
protein
infect
hcmv
previous
describ
arcangeletti
et
al
rapidli
lost
even
becom
establish
follow
blockad
rrna
synthesi
deloc
nucleolar
protein
importantli
demonstr
rrna
synthesi
blockad
interfer
develop
hcmv
lytic
infect
latter
like
stop
earli
stage
new
form
protein
target
ahn
hayward
ishov
et
al
arcangeletti
et
al
inde
cell
treat
inhibitor
rrna
transcript
ie
protein
visibl
speckl
possibl
concomit
coloc
fig
accumul
protein
block
import
note
similar
effect
observ
agent
affect
nucleolar
gene
transcript
differ
mechan
use
preferenti
intercal
dna
sequenc
directli
interfer
factor
take
account
differ
natur
drug
highli
unlik
observ
inhibitori
effect
due
direct
action
hcmv
also
worth
mention
lack
ie
protein
accumul
due
shortag
ribosom
necessari
synthesi
protein
effect
observ
rel
brief
time
cell
cultiv
condit
rrna
transcript
suppress
furthermor
present
evid
indic
inhibit
rrna
transcript
result
overal
decreas
matur
rrna
present
cell
fig
thu
appear
evid
regulatori
pathway
exist
block
progress
hcmv
infect
follow
inhibit
rrna
synthesi
end
worth
mention
mani
virus
abl
affect
activ
nucleolar
gene
differ
mechan
exampl
report
hiv
tat
protein
local
nucleoli
interact
fibrillarin
lead
impair
rrna
matur
well
signific
decreas
number
cytoplasm
ribosom
direct
cell
toward
apoptosi
ponti
et
al
addit
polioviru
induc
rrna
synthesi
banerje
et
al
wherea
adenoviru
infect
lead
nucleolar
dysfunct
disrupt
rrna
process
transport
cytoplasm
lawrenc
et
al
herpesvirus
infect
herp
simplex
viru
type
shown
induc
earli
cellular
protein
synthesi
synthesi
rrna
ribosom
protein
well
ribosom
assembl
proceed
late
time
point
infect
nevertheless
ribosom
show
sever
modif
includ
unusu
pattern
phosphoryl
associ
cellular
viral
protein
simonin
et
al
diaz
et
al
unlik
herpesvirus
hcmv
abl
stimul
host
cell
rna
synthesi
includ
ribosom
rna
tanaka
et
al
jarskaja
et
al
accompani
profound
reorgan
nucleolu
jarskaja
et
al
therefor
like
presenc
hcmv
compon
within
nucleolar
compart
import
viru
order
redirect
nucleolar
function
benefit
although
function
remain
fulli
understood
mani
observ
suggest
protein
involv
regul
initi
event
viral
replic
first
hypothesi
support
previou
observ
made
group
regard
nucleolar
nuclear
matrix
local
incom
de
novo
synthes
sanchez
et
al
arcangeletti
et
al
furthermor
report
kinas
activ
britt
auger
somogyi
et
al
interact
viral
andor
cellular
kinas
gallina
et
al
kamil
coen
final
dal
mont
collabor
found
hcmv
replic
vitro
suppress
absenc
function
dal
mont
et
al
present
data
reinforc
hypothesi
postul
involv
viral
tegument
protein
regulatorysign
pathway
suggest
latter
link
function
nucleolu
depend
directli
indirectli
rdna
transcript
respect
might
import
control
cell
cycl
mammalian
cell
connect
biogenesi
ribosom
nucleolar
level
ruggero
pandolfi
pliss
et
al
increas
rrna
synthesi
ribosom
assembl
necessari
satisfi
increas
need
newli
synthes
protein
begin
phase
hand
known
hcmv
abl
modifi
normal
progress
cell
cycl
benefit
block
cycl
cell
bain
sinclair
nucleolar
compon
control
phase
mostli
modul
phosphoryl
level
transcript
factor
influenc
interact
activ
polymeras
transcript
machineri
russel
zomerdijk
thu
like
target
nucleolu
incom
possess
kinas
activ
repres
crucial
strategi
adopt
hcmv
take
regulatori
system
control
cell
cycl
progress
order
ensur
correct
develop
lytic
program
work
current
progress
identifi
nucleolar
partner
test
possibl
relationship
viral
protein
nucleolu
rrna
synthesi
regul
hcmv
gene
express
